Law firm Maurice Blackburn has fired its opening salvo in a high-stakes appeal of a judge’s decision rejecting its class action against BHP over the Brazilian dam failure, saying the ruling deprived group members of pocketing higher net returns on any recovery and of choosing a more experienced firm to run the case for them.
A shareholder class action against Woolworths related to its downward revision of a 2015 profit guidance is seeking emails and other documents from a slew of current and former company executives, including the grocery chain’s former Chairman and CEO, who departed in the wake of disappointing financial results.
The battle over competing shareholder class actions against logistics tech company GetSwift is over, with the High Court rejecting a bid by one of the losing class action applicants to take another look at their case.
US-toy giant Mattel has reached a settlement in a Federal Court case alleging its Mecard toys infringed on a patent for a toy transformation mechanism owned by Canadian toy company Spin Master.
An Australian marketing company that allows clients to schedule socal media posts has won a temporary court injunction against Facebook and Instagram in a lawsuit alleging a decision to block the startup from their platforms is a misuse of market power.
Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
A Federal Court judge has questioned whether appeals from IP Australia should be allowed to proceed as hearings anew and not confined to the issues already run before the agency, in a ruling spanning 1,784 paragraphs that dismisses a challenge by chemical manufacturer SNF to a delegate’s decisions granting two mining patents to rival BASF.
Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the Commissioner of Patents regarding a licence to make a cheaper version of the bestselling antidepressant Lexapro.
Baby food maker Bellamy’s is not giving up its fight to limit the costs of two shareholder class actions against the company, lodging an appeal of a ruling that shut down its cost-capping bid as premature.